483
Lovelace Biomedical Research InstituteFDA 483 - Lovelace Biomedical Research Institute - September 13, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Lovelace Respiratory Research Institute was cited for deficiencies in assuring data integrity and maintaining quality assurance during nonclinical laboratory studies. The inspection revealed that the study director failed to ensure accurate recording and verification of experimental data, specifically regarding test article preparation. Furthermore, the quality assurance unit did not maintain a complete master schedule for all nonclinical laboratory studies.
Open in Dashboard
ID · 2cc69e59-a746-45c0-8ae0-e016b5b84b9e